Literature DB >> 30530823

Disease progression of Takayasu arteritis in two patients treated with tocilizumab.

Catalina Sanchez-Alvarez1, Matthew Koster2, Ali Duarte-García2, Kenneth J Warrington2.   

Abstract

Entities:  

Keywords:  Takayasu Arteritis; autoimmune diseases; inflammation; systemic vasculitis

Year:  2018        PMID： 30530823     DOI： 10.1136/annrheumdis-2018-214642

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  Cytokines, growth factors and proteases in medium and large vessel vasculitis.

Authors:  Cornelia M Weyand; Ryu Watanabe; Hui Zhang; Mitsuhiro Akiyama; Gerald J Berry; Jörg J Goronzy
Journal:  Clin Immunol       Date:  2019-02-14       Impact factor: 3.969

2.  Childhood-onset Takayasu Arteritis.

Authors:  Florence A Aeschlimann; Marinka Twilt; Rae S M Yeung
Journal:  Eur J Rheumatol       Date:  2020-02

Review 3.  An Update on Childhood-Onset Takayasu Arteritis.

Authors:  Florence A Aeschlimann; Rae S M Yeung; Ronald M Laxer
Journal:  Front Pediatr       Date:  2022-04-13       Impact factor: 3.569

Review 4.  Innate and Adaptive Immunity in Giant Cell Arteritis.

Authors:  Mitsuhiro Akiyama; Shozo Ohtsuki; Gerald J Berry; David H Liang; Jörg J Goronzy; Cornelia M Weyand
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

5.  Inhibition of IL-6 in the LCWE Mouse Model of Kawasaki Disease Inhibits Acute Phase Reactant Serum Amyloid A but Fails to Attenuate Vasculitis.

Authors:  Rebecca A Porritt; Carol Chase Huizar; Edward J Dick; Shyamesh Kumar; Renee Escalona; Angela C Gomez; Stefani Marek-Iannucci; Magali Noval Rivas; Jean Patterson; Thomas G Forsthuber; Moshe Arditi; Mark Gorelik
Journal:  Front Immunol       Date:  2021-04-09       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.